A new study found that adults with weight gain or obesity and type 2 diabetes who take the dabagliplozine drug, famous for the commercial name “Forsiga”, along with the moderate traditional calories, achieve much higher rates of calories compared to the calorie restriction alone.
The threat in diabetes is to maintain blood sugar levels in the normal range for at least two months after you stop taking anti -diabetes medications.
The study was conducted by researchers from the Department of Endocrine and metabolism at the University of Chungshan Hospital of the University of Vodan, China, and published in the “BMG” magazine on January 22, and wrote the Yorick Alrt website.
The researchers say that this study provides a practical strategy to achieve calm for patients with type 2 diabetes when the disease is in its infancy.
Participants ranged between 20 and 70 with a BMI greater than 25, and they did not take any anti -diabetes medication other than metformin.
After 12 months, 44% of the participants in the calorie restriction group were in addition to the Dapaglevlozine in a calm condition compared to 28% in the imaginary drug group, and there was a much larger decrease in body weight and insulin resistance in the Dapaglevlozine group.
The results also showed the benefits of Dapaglevlozen for the body of body fat, blood pressure and cholesterol levels.
Dabaglevlozine is a family of sodium-2 inhibitors that reduce blood sugar in type 2 diabetes by inhibiting renal glucose absorption and increased glucose secretion in the urine.